Error: Could not add to watchlist. X
+ Watchlist

Fennec Pharmaceuticals Inc

AHX:CN
Ticker Change
AHX:CN has changed to a new ticker symbol
CAD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (CAD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.06%
% Price Change
+0.10%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Fennec Pharmaceuticals Inc. is a biopharmaceutical company focused on the development of Sodium Thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients.
Address
68 TW Alexander Drive
PO Box 13628
Research Triangle Park, NC 27709
United States
Phone
1-919-636-4530
Show More